Hinge Health Inc
NYSE:HNGE
Relative Value
There is not enough data to reliably calculate the relative value of HNGE.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
HNGE Competitors Multiples
Hinge Health Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
H
|
Hinge Health Inc
NYSE:HNGE
|
3.2B USD | 0 | 0 | 0 | 0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 0.2 | 56.1 | 14.2 | 14.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.2B USD | 0.3 | 12.5 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
63.9B EUR | 0.3 | 12.2 | 7.8 | 10 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
29B EUR | 1.3 | 26.1 | 10.9 | 16.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR | 1.2 | 33.9 | 10.1 | 21.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.4B USD | 1.7 | 26.9 | 12.8 | 18.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.2B USD | 2.1 | 23.4 | 12.8 | 17.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.3B EUR | 0.6 | 15.7 | 6.3 | 13.4 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.8B USD | 13 | -30.7 | -32.9 | -29.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 14.1 | 7.3 | 9.9 |